Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Diversifying crypto portfolios reduces concentration risk and smooths performance across market cycles. A varied mix helps you weather downturns while maintaining growth opportunities.
22,783 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
As March opens, SoFi Technologies jumps after an active insider purchase by CEO Anthony Noto. This deep dive breaks d...
Discover what to expect from Urban One's 2025 earnings. This guide breaks down revenue drivers, margins, and strategi...
China’s export engine and structural advantages are shaping a landscape where trade deals matter less than the decade...
When a chief operating officer sells shares, investors often wonder what it really means. This guide explains how to ...
AMD’s latest earnings call highlights a rapid AI-led growth wave and a massive server CPU opportunity. Here are the f...
During 13F season, big investors reveal shifts in their portfolios. This piece explains the move, why Microsoft was f...
Energy stocks are rallying as market volatility persists, highlighting the best stocks right now for investors seekin...
Fidelity has alerted owners of 500-stock funds that the S&P 500 is dominated by a small group of mega-caps, raising q...
Space etfs skyrocketing ahead signal excitement about space tech, but public market exposure comes with unique risks....
A growing cohort of retirees is leaving conventional bond ladders behind as high‑income funds supply near‑12% monthly...
In a year when consumer spending and rural lifestyles intersect, two US retailers sit at opposite ends of the same ma...